Research graph
References from Nanocrystal maturation in doxorubicin liposomes determines functional performance: real-time insights from in situ SAXS. Local targets link to admitted publications; unresolved targets remain external evidence.
In vitro and in vivo characterizations of PEGylated liposomal doxorubicin
10.4155/bio.10.204 · 2011 · External reference
Doxorubicin: nanotechnological overviews from bench to bedside
10.1016/j.drudis.2016.11.005 · 2017 · External reference
Rapid scale-up and production of active-loaded PEGylated liposomes
10.1016/j.ijpharm.2020.119566 · 2020 · External reference
Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil/Caelyx): an updated analysis and future perspective
2025 · External reference
A design-conversed strategy establishes the performance safe space for doxorubicin nanosimilars
10.1021/acsnano.3c08290 · 2024 · External reference
Differences in physico-chemical properties and immunological response in nanosimilar complex drugs: the case of liposomal doxorubicin
10.3390/ijms241713612 · 2023 · External reference
Doxil ®-the first FDA approved nano-drug: lessons learned
10.1016/j.jconrel.2012.03.020 · 2012 · External reference
Gelation of liposome interior. A novel method for drug encapsulation
1992 · External reference
Drug nanocrystallisation within liposomes
10.1016/j.jconrel.2018.09.001 · 2018 · External reference
Quantitative cryo-TEM reveals new structural details of Doxil-like PEGylated liposomal Doxorubicin formulation
10.3390/pharmaceutics13010123 · 2021 · External reference
An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome
10.1016/j.jconrel.2015.11.021 · 2016 · External reference
Folded, undulating, and fibrous doxorubicin sulfate crystals in liposomes
2023 · External reference
A comparative study on physicochemical and analytical characterizations of Doxil® and its generic drug products
10.1208/s12248-025-01058-1 · 2025 · External reference
Cardinal role of intraliposome doxorubicin-sulfate nanorod crystal in Doxil properties and performance
10.1021/acsomega.7b01235 · 2018 · External reference
Insights into composition/structure/function relationships of Doxil® gained from “high-sensitivity” differential scanning calorimetry
10.1016/j.ejpb.2016.04.011 · 2016 · External reference
Heating treatments affect the thermal behavior of doxorubicin loaded in PEGylated liposomes
10.1016/j.ijpharm.2017.09.069 · 2017 · External reference
Encapsulation of doxorubicin in magnesium acetate liposomes as a pH-sensitive drug carrier for tumor therapy
10.1016/j.isci.2025.113336 · 2025 · External reference
Liposome drugs’ loading efficiency: a working model based on loading conditions and drug’s physicochemical properties
10.1016/j.jconrel.2009.05.036 · 2009 · External reference
Changes of the lipid membrane structures caused by chain-length-dependent doxorubicin embedment in PEGylated liposomes
10.1107/s1600576725003577 · 2025 · External reference
Separation of liposome-associated doxorubicin from non-liposome-associated doxorubicin in human plasma: implications for pharmacokinetic studies
10.1016/0005-2736(89)90329-5 · 1989 · External reference
BL19U2: small-angle X-ray scattering beamline for biological macromolecules in solution at SSRF
10.1007/s41365-020-00825-3 · 2021 · External reference
BioXTAS RAW, a software program for high-throughput automated small-angle X-ray scattering data reduction and preliminary analysis
10.1107/s0021889809023863 · 2009 · External reference
Small-angle X-ray scattering for PEGylated liposomal doxorubicin drugs: an analytical model comparison study
10.1021/acs.molpharmaceut.3c00396 · 2023 · External reference
X-ray scattering from unilamellar lipid vesicles
10.1107/s0021889804029206 · 2005 · External reference
Analysis of small-angle scattering data from colloids and polymer solutions: modeling and least-squares fitting
10.1016/s0001-8686(97)00312-6 · 1997 · External reference
Using solution X-ray scattering to determine the high-resolution structure and morphology of PEGylated liposomal doxorubicin nanodrugs
10.1016/j.bbagen.2015.09.012 · 2016 · External reference
SASfit: a tool for small-angle scattering data analysis using a library of analytical expressions
10.1107/s1600576715016544 · 2015 · External reference
In vitro experiments showing enhanced release of doxorubicin from Doxil® in the presence of ammonia may explain drug release at tumor site
10.1016/j.nano.2015.06.007 · 2015 · External reference
Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient
10.1016/s0005-2736(98)00175-8 · 1998 · External reference
Nanomorphology tuning in doxorubicin-loaded liposomes via cooling-induced doxorubicin-crystallization and membrane phase transition
10.1039/d5cc02434j · 2025 · External reference
Leakage kinetics of the liposomal chemotherapeutic agent Doxil: the role of dissolution, protonation, and passive transport, and implications for mechanism of action
10.1016/j.jconrel.2017.11.007 · 2018 · External reference
Mechanistic model and analysis of doxorubicin release from liposomal formulations
10.1016/j.jconrel.2015.08.024 · 2015 · External reference
Crystal structure and conformational analysis of doxorubicin nitrate
10.1107/s2056989018002955 · 2018 · External reference
